Ann: Annual General Meeting Addresses and Presentation, page-75

But others will note Parsons and RTX and follow suit. No one wants to be left behind. That is the whole point.
Onsor is launching Nexa in 2026. Others will not want to be left behind. Wearables with AKIDA will follow, perhaps heart issues, migraines, Parkinsons etc.
Onsor are likely developing further health wearables themselves - its not likely they will be content to be a one trick pony. Neuromorphic growth will be exponential and no one that will benefit from it will want to be left out.
Kevin Johnson has only scratched the surface with use cases.
It was made very clear today that progress with partners cannot be discussed. Partners would find that inappropriate and it may be subject to NDA. A partners progress is their business until they sign a contract.
We were told today that the pipeline was expanding.
Yes its frustrating but our adoption timeline will eventually become out moat as any newcomers will have to endure years of testing as well.